Sasa Sega

Summary

Affiliation: University Medical Centre
Country: Slovenia

Publications

  1. ncbi IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines
    Sasa Sega
    Department of Neurology, University Clinical Centre Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 106:255-8. 2004
  2. ncbi Immunomodulatory treatment of MS in Slovenia
    Sasa Sega-Jazbec
    Department of Neurology, University Medical Centre Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 104:249-50. 2002
  3. ncbi Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients. Report of two cases
    Sasa Sega
    Department of Neurology, University Clinical Centre, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 108:259-65. 2006
  4. ncbi Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients?
    Sasa Sega
    Department of Neurology, University Clinical Centre Ljubljana, Ljubljana, Slovenia
    Clin Neurol Neurosurg 110:947-50. 2008

Collaborators

Detail Information

Publications4

  1. ncbi IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines
    Sasa Sega
    Department of Neurology, University Clinical Centre Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 106:255-8. 2004
    ....
  2. ncbi Immunomodulatory treatment of MS in Slovenia
    Sasa Sega-Jazbec
    Department of Neurology, University Medical Centre Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 104:249-50. 2002
  3. ncbi Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients. Report of two cases
    Sasa Sega
    Department of Neurology, University Clinical Centre, Zaloska 7, 1525 Ljubljana, Slovenia
    Clin Neurol Neurosurg 108:259-65. 2006
    ..Although interferon-beta has been said to function as a tumor-suppressor protein, the influence of long-term treatment of MS patients on cancer development is not known...
  4. ncbi Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients?
    Sasa Sega
    Department of Neurology, University Clinical Centre Ljubljana, Ljubljana, Slovenia
    Clin Neurol Neurosurg 110:947-50. 2008
    ..The objectives of the study were to compare cytokines levels (IFN-gamma, IL-4, IL-6, IL-10) and expression of adhesion molecules before and during treatment in responders and nonresponders to IFN-beta treatment...